Skip to search formSkip to main contentSkip to account menu

Lilly 127935

Known as: Ly 127935, Ly-127935, Ly127935 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1980
Highly Cited
1980
Highly Cited
1980
The pharmacokinetics of 1-oxa-β-lactam (LY127935), a new semisynthetic β-lactam antibiotic, was studied in four healthy adult… 
1980
1980
The activity of cefoperazone, a new broad-spectrum cephalosporin, was tested in vitro against 670 clinical isolates of gram… 
1980
1980
Hemophilus influenzae isolates from sputum of 111 patients with chronic bronchitis were tested for susceptibility to 8… 
1980
1980
The in vitro activity of 1-oxa-beta-lactam (LY127935), cefoperazone (T-1551), cefuroxime, cefsulodin, cefaclor, cefotaxime, and… 
1980
1980
In vitro susceptibilities of 53 clinical isolates of Pseudomonas aeruginosa to nine antipseudomonal antibiotics were determined… 
1980
1980
The in vitro activities of moxalactam (LY127935 [6059S]) and cefotaxime were compared with those of cefoxitin, cefamandole… 
Highly Cited
1979
Highly Cited
1979
The in vitro activity of LY-127935, a new beta-lactam antibiotic, was examined by using 370 clinical bacterial strains. In… 
Highly Cited
1979
Highly Cited
1979
LY127935 is a unique new β-lactam antibiotic. Its activity against 536 clinical isolates was studied by using microdilution… 
1979
1979
The in vitro activities of LY127935 (LY) were compared with those of other beta-lactam antibiotics. LY was highly active (minimal…